Expanding Immunotherapy Use Boosts US Non-Small Cell Lung Cancer...

added blog Other

2026-06-10 14:43:22

Expanding Immunotherapy Use Boosts US Non-Small Cell Lung Cancer Market Growth

The United States represents the largest contributor to the NSCLC market due to its extensive oncology care network, strong clinical research ecosystem, and high healthcare expenditure. The country continues to witness significant advancements in targeted therapies aimed at specific genetic mutations such as EGFR, ALK, ROS1, and KRAS. Increased utilization of immunotherapy drugs and combination...

0 Comments 0 Shares 34 Views 0 Reviews